Geza Toth, Ph.D. - Publications

Affiliations: 
2000 University of Notre Dame, Notre Dame, IN, United States 
Area:
Electronics and Electrical Engineering, Condensed Matter Physics

148 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Camacho E, Marie N, Dupas Q, Martel C, Nowoczyn M, Elie N, Rochais C, Töth G, Allouche S. Impact of T161, Y318 and S363 alanine mutations on regulation of the human delta-opioid receptor (hDOPr) induced by peptidic and alkaloid agonists. Neuropharmacology. 108286. PMID 32841607 DOI: 10.1016/J.Neuropharm.2020.108286  0.314
2020 Tóth G, Vértesi T, Horodecki P, Horodecki R. Activating Hidden Metrological Usefulness. Physical Review Letters. 125: 020402. PMID 32701319 DOI: 10.1103/Physrevlett.125.020402  0.305
2020 Kong J, Jiménez-Martínez R, Troullinou C, Lucivero VG, Tóth G, Mitchell MW. Measurement-induced, spatially-extended entanglement in a hot, strongly-interacting atomic system. Nature Communications. 11: 2415. PMID 32415093 DOI: 10.1038/S41467-020-15899-1  0.322
2018 Lange K, Peise J, Lücke B, Kruse I, Vitagliano G, Apellaniz I, Kleinmann M, Tóth G, Klempt C. Entanglement between two spatially separated atomic modes. Science (New York, N.Y.). 360: 416-418. PMID 29700263 DOI: 10.1126/Science.Aao2035  0.311
2018 Blair EP, Toth G, Lent CS. Entanglement loss in molecular quantum-dot qubits due to interaction with the environment. Journal of Physics. Condensed Matter : An Institute of Physics Journal. PMID 29578454 DOI: 10.1088/1361-648X/Aab98D  0.594
2018 Tóth G, Vértesi T. Quantum States with a Positive Partial Transpose are Useful for Metrology. Physical Review Letters. 120: 020506. PMID 29376687 DOI: 10.1103/Physrevlett.120.020506  0.313
2018 Vitagliano G, Colangelo G, Martin Ciurana F, Mitchell MW, Sewell RJ, Tóth G. Entanglement and extreme planar spin squeezing Physical Review A. 97. DOI: 10.1103/Physreva.97.020301  0.331
2017 Yoo JH, Borsodi A, Tóth G, Benyhe S, Gaspar R, Matifas A, Kieffer BL, Metaxas A, Kitchen I, Bailey A. Characterization of [(3)H] oxymorphone binding sites in mouse brain: quantitative autoradiography in opioid receptor knockout mice. Neuroscience Letters. PMID 28192197 DOI: 10.1016/J.Neulet.2017.02.002  0.344
2017 Apellaniz I, Kleinmann M, Gühne O, Toth G. Optimal witnessing of the quantum Fisher information with few measurements Physical Review A. 95. DOI: 10.1103/Physreva.95.032330  0.341
2015 Tóth F, Mallareddy JR, Tourwé D, Lipkowski AW, Bujalska-Zadrozny M, Benyhe S, Ballet S, Tóth G, Kleczkowska P. Synthesis and binding characteristics of [(3)H]neuromedin N, a NTS2 receptor ligand. Neuropeptides. PMID 26707235 DOI: 10.1016/J.Npep.2015.12.004  0.332
2015 Budroni C, Vitagliano G, Colangelo G, Sewell RJ, Gühne O, Tóth G, Mitchell MW. Quantum Nondemolition Measurement Enables Macroscopic Leggett-Garg Tests. Physical Review Letters. 115: 200403. PMID 26613423 DOI: 10.1103/Physrevlett.115.200403  0.315
2015 Tóth G, Moroder T, Gühne O. Evaluating convex roof entanglement measures. Physical Review Letters. 114: 160501. PMID 25955038 DOI: 10.1103/Physrevlett.114.160501  0.307
2015 Guerrieri E, Mallareddy JR, Tóth G, Schmidhammer H, Spetea M. Synthesis and pharmacological evaluation of [(3)H]HS665, a novel, highly selective radioligand for the kappa opioid receptor. Acs Chemical Neuroscience. 6: 456-63. PMID 25496417 DOI: 10.1021/Cn5002792  0.366
2015 Eltschka C, Tóth G, Siewert J. Partial transposition as a direct link between concurrence and negativity Physical Review A. 91: 32327. DOI: 10.1103/Physreva.91.032327  0.308
2014 Tomczyszyn A, Csibrany B, Keresztes A, Mallareddy JR, Dyniewicz J, Misicka A, Toth G, Lipkowski AW. In vitro pharmacological evaluation of the radiolabeled C-terminal substance P analogue Lys-Phe-Phe-Gly-Leu-Met-NH2: Does a specific binding site exist? Folia Neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. 52: 383-9. PMID 25574743 DOI: 10.5114/Fn.2014.47839  0.322
2014 Perlikowska R, Piekielna J, Fichna J, do-Rego JC, Toth G, Janecki T, Janecka A. Pharmacological properties of novel cyclic pentapeptides with µ-opioid receptor agonist activity. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 10: 154-61. PMID 23628088 DOI: 10.2174/157340641002140131161135  0.35
2014 Tóth G, Apellaniz I. Quantum metrology from a quantum information science perspective Journal of Physics A. 47: 424006. DOI: 10.1088/1751-8113/47/42/424006  0.343
2013 Murányi M, Cinar R, Kékesi O, Birkás E, Fábián G, Bozó B, Zentai A, Tóth G, Kicsi EG, Mácsai M, Dochnal R, Szabó G, Szücs M. Ligand-specific regulation of the endogenous mu-opioid receptor by chronic treatment with mu-opioid peptide agonists. Biomed Research International. 2013: 501086. PMID 24350273 DOI: 10.1155/2013/501086  0.376
2013 Fichna J, Mazur M, Grzywacz D, Kamysz W, Perlikowska R, Piekielna J, Sobczak M, Sałaga M, Toth G, Janecka A, Chen C, Olczak J. Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration. Bioorganic & Medicinal Chemistry Letters. 23: 6673-6. PMID 24220171 DOI: 10.1016/J.Bmcl.2013.10.041  0.348
2013 Tóth G, Mallareddy JR. Tritiated opioid receptor ligands as radiotracers. Current Pharmaceutical Design. 19: 7461-72. PMID 23448471 DOI: 10.2174/138161281942140105170259  0.346
2013 Paldy E, Borcel E, Higuera-Matas A, López-Montoya G, Wenger T, Toth G, Borsodi A, Ambrosio E. CNR1 gene deletion affects the density of endomorphin-2 binding sites in the mouse brain in a hemisphere-specific manner. European Journal of Pharmacology. 698: 220-7. PMID 23142371 DOI: 10.1016/J.Ejphar.2012.10.043  0.324
2013 Szentirmay AK, Király KP, Lenkey N, Lackó E, Al-Khrasani M, Friedmann T, Timár J, Gyarmati S, Tóth G, Fürst S, Riba P. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice. Brain Research Bulletin. 90: 66-71. PMID 22995282 DOI: 10.1016/J.Brainresbull.2012.09.006  0.338
2013 Tóth G, Petz D. Extremal properties of the variance and the quantum Fisher information Physical Review A. 87: 32324. DOI: 10.1103/Physreva.87.032324  0.316
2012 Borics A, Mallareddy JR, Timári I, Kövér KE, Keresztes A, Tóth G. The effect of Pro(2) modifications on the structural and pharmacological properties of endomorphin-2. Journal of Medicinal Chemistry. 55: 8418-28. PMID 22957923 DOI: 10.1021/Jm300836N  0.357
2012 Tóth F, Tóth G, Benyhe S, Rougeot C, Wollemann M. Opiorphin highly improves the specific binding and affinity of MERF and MEGY to rat brain opioid receptors. Regulatory Peptides. 178: 71-5. PMID 22771829 DOI: 10.1016/J.Regpep.2012.06.011  0.348
2012 Aguila B, Coulbault L, Davis A, Marie N, Hasbi A, Le bras F, Tóth G, Borsodi A, Gurevich VV, Jauzac P, Allouche S. ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands. Cellular Signalling. 24: 699-707. PMID 22101011 DOI: 10.1016/J.Cellsig.2011.10.018  0.347
2012 Spetea M, Berzetei-Gurske IP, Guerrieri E, Mallareddy J, Tóth G, Schmidhammer H. Discovery and biological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective κ opioid receptor agonist Bmc Clinical Pharmacology. 13: 1-2. DOI: 10.1186/2050-6511-13-S1-A43  0.359
2011 Fichna J, Perlikowska R, Wyrębska A, Gach K, Piekielna J, do-Rego JC, Toth G, Kluczyk A, Janecki T, Janecka A. Effect of 2',6'-dimethyl-L-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs. Bioorganic & Medicinal Chemistry. 19: 6977-81. PMID 22047797 DOI: 10.1016/J.Bmc.2011.10.040  0.352
2011 De Wachter R, de Graaf C, Keresztes A, Vandormael B, Ballet S, Tóth G, Rognan D, Tourwé D. Synthesis, biological evaluation, and automated docking of constrained analogues of the opioid peptide H-Dmt-D-Ala-Phe-Gly-NH₂ using the 4- or 5-methyl substituted 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one scaffold. Journal of Medicinal Chemistry. 54: 6538-47. PMID 21870874 DOI: 10.1021/Jm2003574  0.371
2011 Mallareddy JR, Borics A, Keresztes A, Kövér KE, Tourwé D, Tóth G. Design, synthesis, pharmacological evaluation, and structure-activity study of novel endomorphin analogues with multiple structural modifications. Journal of Medicinal Chemistry. 54: 1462-72. PMID 21287991 DOI: 10.1021/Jm101515V  0.352
2011 Borics A, Mallareddy JR, Kövér KE, Tóth G. A putative pharmacophore model of μ-opioid receptor activity Pharmacological Reports. 63: 227-228. DOI: 10.1016/S1734-1140(11)70446-7  0.321
2010 Gach K, do-Rego JC, Fichna J, Storr M, Delbro D, Toth G, Janecka A. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs. Peptides. 31: 1617-24. PMID 20434497 DOI: 10.1016/J.Peptides.2010.04.018  0.328
2010 Borics A, Tóth G. Structural comparison of mu-opioid receptor selective peptides confirmed four parameters of bioactivity. Journal of Molecular Graphics & Modelling. 28: 495-505. PMID 20036591 DOI: 10.1016/J.Jmgm.2009.11.006  0.366
2010 Perlikowska R, do-Rego JC, Cravezic A, Fichna J, Wyrebska A, Toth G, Janecka A. Synthesis and biological evaluation of cyclic endomorphin-2 analogs. Peptides. 31: 339-45. PMID 19995587 DOI: 10.1016/J.Peptides.2009.12.002  0.376
2010 Perlikowska R, Fichna J, Wyrebska A, Poels J, Vanden Broeck J, Toth G, Storr M, do Rego JC, Janecka A. Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 2. Basic & Clinical Pharmacology & Toxicology. 106: 106-13. PMID 19874287 DOI: 10.1111/J.1742-7843.2009.00476.X  0.344
2010 Tóth G, Wieczorek W, Gross D, Krischek R, Schwemmer C, Weinfurter H. Permutationally invariant quantum tomography Physical Review Letters. 105. DOI: 10.1103/Physrevlett.105.250403  0.312
2009 Demaegdt H, Lukaszuk A, De Buyser E, De Backer JP, Szemenyei E, Tóth G, Chakravarthy S, Panicker M, Michotte Y, Tourwé D, Vauquelin G. Selective labeling of IRAP by the tritiated AT(4) receptor ligand [3H]Angiotensin IV and its stable analog [3H]AL-11. Molecular and Cellular Endocrinology. 311: 77-86. PMID 19643163 DOI: 10.1016/J.Mce.2009.07.020  0.315
2009 Tóth G, Gühne O. Entanglement and permutational symmetry. Physical Review Letters. 102: 170503. PMID 19518768 DOI: 10.1103/Physrevlett.102.170503  0.306
2009 Perlikowska R, Gach K, Fichna J, Toth G, Walkowiak B, do-Rego JC, Janecka A. Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2. Bioorganic & Medicinal Chemistry. 17: 3789-94. PMID 19435668 DOI: 10.1016/J.Bmc.2009.04.046  0.364
2009 Bojnik E, Magyar A, Tóth G, Bajusz S, Borsodi A, Benyhe S. Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences Neuroscience. 158: 867-874. PMID 18977279 DOI: 10.1016/J.Neuroscience.2008.09.056  0.355
2009 Wachter RD, Brans L, Ballet S, Eynde IVd, Feytens D, Keresztes A, Toth G, Urbanczyk-Lipkowska Z, Tourwé D. Influence of ring substitution on the conformation and β-turn mimicry of 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one peptide mimetics Tetrahedron. 65: 2266-2278. DOI: 10.1016/J.Tet.2009.01.057  0.303
2009 Tóth G, Gühne O. Separability criteria and entanglement witnesses for symmetric quantum states Applied Physics B. 98: 617-622. DOI: 10.1007/S00340-009-3839-7  0.328
2008 Ibba M, Kitayama M, McDonald J, Calo G, Guerrini R, Farkas J, Toth G, Lambert DG. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 378: 553-61. PMID 18807245 DOI: 10.1007/S00210-008-0350-3  0.322
2008 Botros M, Johansson T, Zhou Q, Lindeberg G, Tömböly C, Tóth G, Le Grevès P, Nyberg F, Hallberg M. Endomorphins interact with the substance P (SP) aminoterminal SP(1-7) binding in the ventral tegmental area of the rat brain. Peptides. 29: 1820-4. PMID 18597894 DOI: 10.1016/J.Peptides.2008.05.014  0.342
2008 Keresztes A, Szucs M, Borics A, Kövér KE, Forró E, Fülöp F, Tömböly C, Péter A, Páhi A, Fábián G, Murányi M, Tóth G. New endomorphin analogues containing alicyclic beta-amino acids: influence on bioactive conformation and pharmacological profile. Journal of Medicinal Chemistry. 51: 4270-9. PMID 18572932 DOI: 10.1021/Jm800223T  0.329
2008 Staniszewska R, Fichna J, Gach K, Toth G, Poels J, Vanden Broeck J, Janecka A. Synthesis and biological activity of endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic acids instead of proline in position 2. Chemical Biology & Drug Design. 72: 91-4. PMID 18564215 DOI: 10.1111/J.1747-0285.2008.00678.X  0.312
2008 Szemenyei E, Barna I, Mergl Z, Keresztes A, Darula Z, Kató E, Tóth G, Rónai AZ. Detection of a novel immunoreactive endomorphin 2-like peptide in rat brain extracts. Regulatory Peptides. 148: 54-61. PMID 18440655 DOI: 10.1016/J.Regpep.2008.03.001  0.34
2008 Birkas E, Kertesz I, Toth G, Bakota L, Gulya K, Szucs M. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH. Neuropeptides. 42: 57-67. PMID 18068762 DOI: 10.1016/J.Npep.2007.10.003  0.376
2008 Tömböly C, Ballet S, Feytens D, Kövér KE, Borics A, Lovas S, Al-Khrasani M, Fürst Z, Tóth G, Benyhe S, Tourwé D. Endomorphin-2 with a beta-turn backbone constraint retains the potent micro-opioid receptor agonist properties. Journal of Medicinal Chemistry. 51: 173-7. PMID 18062664 DOI: 10.1021/Jm7010222  0.316
2008 Tóth G. QUBIT4MATLAB V3.0: A program package for quantum information science and quantum optics for MATLAB Computer Physics Communications. 179: 430-437. DOI: 10.1016/J.Cpc.2008.03.007  0.309
2007 Gonzalez-Nuñez V, Toth G, Rodríguez RE. Endogenous heptapeptide Met-enkephalin-Gly-Tyr binds differentially to duplicate delta opioid receptors from zebrafish. Peptides. 28: 2340-7. PMID 18022288 DOI: 10.1016/J.Peptides.2007.10.002  0.377
2007 Aguila B, Coulbault L, Boulouard M, Léveillé F, Davis A, Tóth G, Borsodi A, Balboni G, Salvadori S, Jauzac P, Allouche S. In vitro and in vivo pharmacological profile of UFP-512, a novel selective δ-opioid receptor agonist; correlations between desensitization and tolerance British Journal of Pharmacology. 152: 1312-1324. PMID 17982482 DOI: 10.1038/Sj.Bjp.0707497  0.331
2007 Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles. Brain Research Bulletin. 74: 119-29. PMID 17683797 DOI: 10.1016/J.Brainresbull.2007.05.010  0.375
2007 Kiesel N, Schmid C, Tóth G, Solano E, Weinfurter H. Experimental observation of four-photon entangled Dicke state with high fidelity. Physical Review Letters. 98: 63604-63604. PMID 17358941 DOI: 10.1103/Physrevlett.98.063604  0.325
2007 Stevens CW, Tóth G, Borsodi A, Benyhe S. Xendorphin B1, a novel opioid-like peptide determined from a Xenopus laevis brain cDNA library, produces opioid antinociception after spinal administration in amphibians. Brain Research Bulletin. 71: 628-32. PMID 17292806 DOI: 10.1016/J.Brainresbull.2006.12.001  0.327
2007 Ballet S, Wachter RD, Rompaey KV, Tömböly C, Feytens D, Töth G, Quartara L, Cucchi P, Meini S, Tourwé D. Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus. Journal of Peptide Science. 13: 164-170. PMID 17266049 DOI: 10.1002/Psc.827  0.344
2007 Tóth G, Ioja E, Tömböly C, Ballet S, Tourwé D, Péter A, Martinek T, Chung NN, Schiller PW, Benyhe S, Borsodi A. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists. Journal of Medicinal Chemistry. 50: 328-33. PMID 17228874 DOI: 10.1021/Jm060721U  0.332
2007 Tóth G, García-Ripoll JJ. Efficient algorithm for multiqudit twirling for ensemble quantum computation Physical Review A. 75. DOI: 10.1103/Physreva.75.042311  0.306
2007 Aguila B, Coulbault L, Boulouard M, Léveillé F, Davis A, Tóth G, Borsodi A, Balboni G, Salvadori S, Jauzac P, Allouche S. Erratum: In vitro and in vivo pharmacological profile of UFP-512, a novel selective δ-opioid receptor agonist; Correlations between desensitization and tolerance (British Journal of Pharmacology (2007) 152, (1312-1324) DOI: 1038/sj.bjp.0707497) British Journal of Pharmacology. 152. DOI: 10.1038/Sj.Bjp.0707613  0.328
2007 Szemenyei E, Tóth G. Tritium labelling and degradation studies of Dmt1-endomorphin 2 Journal of Labelled Compounds and Radiopharmaceuticals. 50: 1148-1152. DOI: 10.1002/Jlcr.1402  0.3
2006 Keresztes A, Tóth G, Fülöp F, Szucs M. Synthesis, radiolabeling and receptor binding of [3H][(1S,2R)ACPC2]endomorphin-2. Peptides. 27: 3315-21. PMID 17084945 DOI: 10.1016/J.Peptides.2006.09.004  0.372
2006 Mahurter L, Garceau C, Marino J, Schmidhammer H, Tóth G, Pasternak GW. Separation of binding affinity and intrinsic activity of the potent mu-opioid 14-methoxymetopon. The Journal of Pharmacology and Experimental Therapeutics. 319: 247-53. PMID 16801454 DOI: 10.1124/Jpet.106.105395  0.363
2006 Rónai AZ, Szemenyei E, Kató E, Kocsis L, Orosz G, Al-Khrasani M, Tóth G. Endomorphin synthesis in rat brain from intracerebroventricularly injected [3H]-Tyr-Pro: a possible biosynthetic route for endomorphins. Regulatory Peptides. 134: 54-60. PMID 16464510 DOI: 10.1016/J.Regpep.2005.12.004  0.336
2006 Rónai AZ, Al-Khrasani M, Benyhe S, Lengyel I, Kocsis L, Orosz G, Tóth G, Kató E, Tóthfalusi L. Partial and full agonism in endomorphin derivatives: comparison by null and operational model. Peptides. 27: 1507-13. PMID 16413634 DOI: 10.1016/J.Peptides.2005.12.003  0.354
2006 Botros M, Hallberg M, Johansson T, Zhou Q, Lindeberg G, Frändberg PA, Tömböly C, Tóth G, Le Grevès P, Nyberg F. Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in the rat spinal cord. Peptides. 27: 753-9. PMID 16216386 DOI: 10.1016/J.Peptides.2005.08.009  0.325
2005 Ioja E, Tóth G, Benyhe S, Tourwe D, Péter A, Tömböly C, Borsodi A. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series. Neuro-Signals. 14: 317-28. PMID 16772734 DOI: 10.1159/000093046  0.394
2005 Ligeti M, Gündüz O, Magyar A, Kató E, Rónai AZ, Vita C, Varga I, Hudecz F, Tóth G, Borsodi A, Benyhe S. Synthesis and biological studies of nociceptin derivatives containing the DTPA chelating group for further labeling with therapeutic radionuclides. Peptides. 26: 1159-66. PMID 15949634 DOI: 10.1016/J.Peptides.2005.01.018  0.355
2005 González-Nuñez V, Arsequell G, Szemenyei E, Toth G, Valencia G, Rodriguez RE. Binding profile of the endogenous novel heptapeptide Met-enkephalin-Gly-tyr in zebrafish and rat brain. The Journal of Pharmacology and Experimental Therapeutics. 314: 862-7. PMID 15901806 DOI: 10.1124/Jpet.105.084558  0.356
2004 Kocsis L, Orosz G, Magyar A, Al-Khrasani M, Kató E, Rónai AZ, Bes B, Meunier JC, Gündüz O, Tóth G, Borsodi A, Benyhe S. Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides. Regulatory Peptides. 122: 199-207. PMID 15491792 DOI: 10.1016/J.Regpep.2004.06.019  0.373
2004 Tóth F, Horváth G, Szikszay M, Farkas J, Tóth G, Borsodi A, Benyhe S. Pharmacological and functional biochemical properties of D-Ala2-D-Nle5-enkephalin-Arg-Phe. Regulatory Peptides. 122: 139-46. PMID 15380931 DOI: 10.1016/J.Regpep.2004.06.017  0.381
2004 Tömböly C, Kövér KE, Péter A, Tourwé D, Biyashev D, Benyhe S, Borsodi A, Al-Khrasani M, Rónai AZ, Tóth G. Structure-activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues. Journal of Medicinal Chemistry. 47: 735-43. PMID 14736254 DOI: 10.1021/Jm0310028  0.323
2004 Tóth G, Keresztes A, Tömböly C, Péter A, Fülöp F, Tourwé D, Navratilova E, Varga É, Roeske WR, Yamamura HI, Szucs M, Borsodi A. New endomorphin analogs with mu-agonist and delta-antagonist properties Pure and Applied Chemistry. 76: 951-957. DOI: 10.1351/Pac200476050951  0.381
2003 Tóth F, Farkas J, Tóth G, Wollemann M, Borsodi A, Benyhe S. Synthesis and binding characteristics of a novel enkephalin analogue, [3H]Tyr-D-Ala-Gly-Phe-D-Nle-Arg-Phe. Peptides. 24: 1433-40. PMID 14706559 DOI: 10.1016/J.Peptides.2003.08.009  0.375
2003 Spetea M, Tóth F, Schütz J, Otvös F, Tóth G, Benyhe S, Borsodi A, Schmidhammer H. Binding characteristics of [3H]14-methoxymetopon, a high affinity mu-opioid receptor agonist. The European Journal of Neuroscience. 18: 290-5. PMID 12887410 DOI: 10.1046/J.1460-9568.2003.02744.X  0.375
2003 Labuz D, Chocyk A, Wedzony K, Toth G, Przewlocka B. Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord. Life Sciences. 73: 403-12. PMID 12759135 DOI: 10.1016/S0024-3205(03)00309-6  0.307
2003 Oakley SM, Toth G, Borsodi A, Kieffer BL, Kitchen I. G-protein coupling of delta-opioid receptors in brains of mu-opioid receptor knockout mice. European Journal of Pharmacology. 466: 91-8. PMID 12679145 DOI: 10.1016/S0014-2999(03)01531-0  0.356
2003 Homicskó KG, Kertész I, Radnai B, Tóth BE, Tóth G, Fülöp F, Fekete MI, Nagy GM. Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat. Neurochemistry International. 42: 19-26. PMID 12441164 DOI: 10.1016/S0197-0186(02)00063-3  0.309
2003 Benyhe S, Gündüz Ö, Farkas J, Kocsis L, Sipos F, Ligeti M, Magyar A, Orosz G, Tóth G, Borsodi A. Characterization of nociceptin binding sites by novel peptide analogs and radioprobes Journal of Neurochemistry. 85: 32-32. DOI: 10.1046/J.1471-4159.85.S2.20_6.X  0.34
2003 Ötvös F, Körtvélyesi T, Tóth G. Structure-activity relationships of endomorphin-1, endomorphin-2 and morphiceptin by molecular dynamics methods Journal of Molecular Structure-Theochem. 666: 345-353. DOI: 10.1016/J.Theochem.2003.08.044  0.314
2002 Clarke S, Czyzyk T, Ansonoff M, Nitsche JF, Hsu MS, Nilsson L, Larsson K, Borsodi A, Toth G, Hill R, Kitchen I, Pintar JE. Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. The European Journal of Neuroscience. 16: 1705-12. PMID 12431223 DOI: 10.1046/J.1460-9568.2002.02239.X  0.361
2002 Lengyel I, Orosz G, Biyashev D, Kocsis L, Al-Khrasani M, Rónai A, Tömböly C, Fürst Z, Tóth G, Borsodi A. Side chain modifications change the binding and agonist properties of endomorphin 2. Biochemical and Biophysical Research Communications. 290: 153-161. PMID 11779147 DOI: 10.1006/Bbrc.2001.6136  0.327
2002 Wollemann M, Farkas J, Tóth G, Benyhe S. Characterization of [3H]Met-enkephalin-Arg6-Phe7 binding to opioid receptors in frog brain membrane preparations. Journal of Neurochemistry. 63: 1460-1465. PMID 7931298 DOI: 10.1046/J.1471-4159.1994.63041460.X  0.37
2002 Kummamuru RK, Timler J, Toth G, Lent CS, Ramasubramaniam R, Orlov AO, Bernstein GH, Snider GL. Power gain in a quantum-dot cellular automata latch Applied Physics Letters. 81: 1332-1334. DOI: 10.1063/1.1499511  0.732
2001 Guerrini R, Caló G, Bigoni R, Rizzi D, Rizzi A, Zucchini M, Varani K, Hashiba E, Lambert DG, Toth G, Borea PA, Salvadori S, Regoli D. Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor. Journal of Medicinal Chemistry. 44: 3956-64. PMID 11689082 DOI: 10.1021/Jm010221V  0.317
2001 Csullog E, Joo G, Toth G, Dobos I, Benedek G, Horvath G. Antinociceptive effect of continuous intrathecal administration of endomorphin-1. Pain. 94: 31-8. PMID 11576742 DOI: 10.1016/S0304-3959(01)00338-4  0.311
2001 Horvath G, Joo G, Dobos I, Klimscha W, Toth G, Benedek G. The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats. Anesthesia and Analgesia. 93: 1018-24. PMID 11574376 DOI: 10.1097/00000539-200110000-00044  0.32
2001 Szatmári I, Biyashev D, Tömböly C, Tóth G, Mácsai M, Szabó G, Borsodi A, Lengyel I. Influence of Degradation on Binding Properties and Biological Activity of Endomorphin 1 Biochemical and Biophysical Research Communications. 284: 771-776. PMID 11396969 DOI: 10.1006/Bbrc.2001.5056  0.364
2001 Tóth G, Lent CS. Quantum computing with quantum-dot cellular automata Physical Review a. Atomic, Molecular, and Optical Physics. 63: 523151-523159. DOI: 10.1103/Physreva.63.052315  0.589
2001 Tóth G, Lent CS. Role of correlation in the operation of quantum-dot cellular automata Journal of Applied Physics. 89: 7943-7953. DOI: 10.1063/1.1368389  0.594
2001 Orlov AO, Kummamuru RK, Ramasubramaniam R, Toth G, Lent CS, Bernstein GH, Snider GL. Experimental demonstration of a latch in clocked quantum-dot cellular automata Applied Physics Letters. 78: 1625-1627. DOI: 10.1063/1.1355008  0.586
2001 Tömböly C, Dixit R, Lengyel I, Borsodi A, Tóth G. Preparation of specifically tritiated endomorphins Journal of Labelled Compounds and Radiopharmaceuticals. 44: 355-363. DOI: 10.1002/Jlcr.463  0.369
2000 Guerrini R, Caló G, Bigoni R, Rizzi A, Varani K, Toth G, Gessi S, Hashiba E, Hashimoto Y, Lambert DG, Borea PA, Tomatis R, Salvadori S, Regoli D. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. Journal of Medicinal Chemistry. 43: 2805-13. PMID 10956188 DOI: 10.1021/Jm990075H  0.335
2000 Bozó B, Farkas J, Tóth G, Wollemann M, Szücs M, Benyhe S. Receptor binding and G-protein activation by new Met5-enkephalin-Arg6-Phe7 derived peptides Life Sciences. 66: 1241-1251. PMID 10737419 DOI: 10.1016/S0024-3205(00)00429-X  0.388
2000 Orlov AO, Amlani I, Kummamuru RK, Ramasubramaniam R, Toth G, Lent CS, Bernstein GH, Snider GL. Experimental demonstration of clocked single-electron switching in quantum-dot cellular automata Applied Physics Letters. 77: 295-297. DOI: 10.1063/1.126955  0.581
1999 Varani K, Rizzi A, Calo G, Bigoni R, Toth G, Guerrini R, Gessi S, Salvadori S, Borea PA, Regoli D. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies. Naunyn-Schmiedebergs Archives of Pharmacology. 360: 270-277. PMID 10543428 DOI: 10.1007/S002109900074  0.368
1999 Szatmári I, Tóth G, Kertész I, Schiller PW, Borsodi A. Synthesis and binding characteristics of [3H] H-Tyr-Ticψ[CH2-NH] Cha-Phe-OH, a highly specific and stable δ-opioid antagonist Peptides. 20: 1079-1083. PMID 10499425 DOI: 10.1016/S0196-9781(99)00101-1  0.38
1999 Benyhe S, Monory K, Farkas J, Tóth G, Guerrini R, Salvadori S, Orosz G, Wollemann M, Borsodi A. Nociceptin binding sites in frog (Rana esculenta) brain membranes. Biochemical and Biophysical Research Communications. 260: 592-596. PMID 10403810 DOI: 10.1006/Bbrc.1999.0907  0.361
1999 Turchan J, Przewłocka B, Toth G, Lasoń W, Borsodi A, Przewłocki R. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat Neuroscience. 91: 971-977. PMID 10391475 DOI: 10.1016/S0306-4522(98)00637-X  0.325
1999 Negri L, Lattanzi R, Borsodi A, Toth G, Salvadori S. Differential Knockdown of δ-Opioid Receptor Subtypes in the Rat Brain by Antisense Oligodeoxynucleotides Targeting mRNA Antisense & Nucleic Acid Drug Development. 9: 203-211. PMID 10355826 DOI: 10.1089/Oli.1.1999.9.203  0.329
1999 Benyhe S, Farkas J, Tóth G, Wollemann M. Characterization of [3H]Met-enkephalin-Arg6-Phe7 binding to multiple sites in rat and guinea pig cerebellum Life Sciences. 64: 1189-1196. PMID 10210261 DOI: 10.1016/S0024-3205(99)00050-8  0.366
1999 Amlani I, Orlov AO, Toth G, Bernstein GH, Lent CS, Snider GL. Digital logic gate using quantum-Dot cellular automata Science (New York, N.Y.). 284: 289-91. PMID 10195887 DOI: 10.1126/Science.284.5412.289  0.585
1999 Varani K, Calo G, Rizzi A, Merighi S, Toth G, Guerrini R, Salvadori S, Borea PA, Regoli D. Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships. British Journal of Pharmacology. 125: 1485-90. PMID 9884077 DOI: 10.1038/Sj.Bjp.0702226  0.368
1999 Szűcs M, Baláslpiri L, Tóth G, Yanaihara N. Synthesis and Receptor Binding of Cys-endomorphin Biomedical Research-Tokyo. 20: 253-258. DOI: 10.2220/Biomedres.20.253  0.314
1999 Tóth G, Orlov AO, Amlani I, Lent CS, Bernstein GH, Snider GL. Conductance suppression due to correlated electron transport in coupled double quantum dots Physical Review B - Condensed Matter and Materials Physics. 60: 16906-16912. DOI: 10.1103/Physrevb.60.16906  0.584
1999 Tóth G, Lent CS. Quasiadiabatic switching for metal-island quantum-dot cellular automata Journal of Applied Physics. 85: 2977-2984. DOI: 10.1063/1.369063  0.569
1999 Orlov AO, Amlani I, Toth G, Lent CS, Bernstein GH, Snider GL. Experimental demonstration of a binary wire for quantum-dot cellular automata Applied Physics Letters. 74: 2875-2877. DOI: 10.1063/1.124043  0.583
1999 Tömböly C, Spetea M, Borsodi A, Tóth G. Synthesis Of Tritium Labelled Endomorphin Ii And Its Stability In The Radioreceptor Assay Czechoslovak Journal of Physics. 49: 893-896. DOI: 10.1007/S10582-999-1014-3  0.326
1999 Kertész I, Tóth G, Balboni G, Guerrini R, Salvadori S. Tritiation of delta opioid-receptor selective antagonist dipeptide ligands with extraordinary affinity containing 2′, 6′dimethyltyrosine Czechoslovak Journal of Physics. 49: 887-892. DOI: 10.1007/S10582-999-1013-4  0.356
1999 Wollemann M, Farkas J, Tóth G, Benyhe S. Comparison of the endogenous heptapeptide Met-enkephalin-Arg6-Phe7 binding in amphibian and mammalian brain. Acta Biologica Hungarica. 50: 297-307. DOI: 10.1007/Bf03543051  0.364
1998 Kelly MD, Hill RG, Borsodi A, Toth G, Kitchen I. Weaning-induced development of delta-opioid receptors in rat brain: differential effects of guanine nucleotides and sodium upon ligand-receptor recognition. British Journal of Pharmacology. 125: 979-86. PMID 9846635 DOI: 10.1038/Sj.Bjp.0702142  0.344
1998 Spetea M, Monory K, Tömböly C, Tóth G, Tzavara E, Benyhe S, Hanoune J, Borsodi A. In VitroBinding and Signaling Profile of the Novel μ Opioid Receptor Agonist Endomorphin 2 in Rat Brain Membranes Biochemical and Biophysical Research Communications. 250: 720-725. PMID 9784412 DOI: 10.1006/Bbrc.1998.9395  0.38
1998 Bakota L, Szikra J, Toth G, Gulya K. Slide-binding characterization and autoradiographic localization of delta opioid receptors in rat and mouse brains with the tetrapeptide antagonist [3H]TIPP. Life Sciences. 63: 1377-85. PMID 9768876 DOI: 10.1016/S0024-3205(98)00402-0  0.359
1998 Spetea M, Nevin ST, Hosztafi S, Rónai AZ, Tóth G, Borsodi A. Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids. Neurochemical Research. 23: 1211-6. PMID 9712193 DOI: 10.1023/A:1020738304036  0.369
1998 Spetea M, Ötvös F, Tóth G, Nguyen TM-, Schiller PW, Vogel Z, Borsodi A. Interaction of agonist peptide [3H]Tyr-D-Ala-Phe-Phe-NH2 with μ- opioid receptor in rat brain and CHO-μ/1 cell line Peptides. 19: 1091-1098. PMID 9700760 DOI: 10.1016/S0196-9781(98)00023-0  0.373
1998 Orlov AO, Amlani I, Toth G, Lent CS, Bernstein GH, Snider GL. Correlated electron transport in coupled metal double dots Applied Physics Letters. 73: 2787-2789. DOI: 10.1063/1.122591  0.58
1998 Kertesz I, Balboni G, Salvadori S, Lazarus L, Toth G. Synthesis of 2′,6′‐dimethyltyrosine containing tritiated delta opioid‐receptor selective antagonist dipeptide ligands with extraordinary affinity Journal of Labelled Compounds and Radiopharmaceuticals. 41: 1083-1091. DOI: 10.1002/(Sici)1099-1344(199812)41:12<1083::Aid-Jlcr155>3.0.Co;2-5  0.313
1997 Spetea M, Darula Z, Tóth G, Borsodi A. Synthesis and binding characteristics of the highly selective radiolabelled deltorphin analogues containing 2-aminotetralin-2-carboxylic acid in position 3. Neuropeptides. 31: 483-488. PMID 9413026 DOI: 10.1016/S0143-4179(97)90043-3  0.365
1997 Benyhe S, Farkas J, Tóth G, Wollemann M. Met5-Enkephalin-Arg6-Phe7, An Endogenous Neuropeptide, Binds To Multiple Opioid And Nonopioid Sites In Rat Brain Journal of Neuroscience Research. 48: 249-258. PMID 9160247 DOI: 10.1002/(Sici)1097-4547(19970501)48:3<249::Aid-Jnr7>3.0.Co;2-F  0.359
1997 Gyires K, Rónai AZ, Tóth G, Darula Z, Fürst S. Analysis of the role of delta opioid receptors in gastroprotection in the rat. Life Sciences. 60: 1337-47. PMID 9096254 DOI: 10.1016/S0024-3205(97)00079-9  0.327
1997 Tóth G, Darula Z, Péter A, Fülöp F, Tourwé D, Jaspers H, Verheyden P, Böcskey Z, Tóth Z, Borsodi A. Conformationally constrained deltorphin analogs with 2-aminotetralin-2-carboxylic acid in position 3. Journal of Medicinal Chemistry. 40: 990-5. PMID 9083489 DOI: 10.1021/Jm9602726  0.364
1997 Darula Z, Péter A, Tóth G. Tritiated deltorphin analogues with high specific radioactivity and high affinity and selectivity for delta opioid receptors Journal of Labelled Compounds and Radiopharmaceuticals. 39: 817-826. DOI: 10.1002/(Sici)1099-1344(199710)39:10<817::Aid-Jlcr28>3.0.Co;2-B  0.301
1996 Toth G, Lent CS, Douglas Tougaw P, Brazhnik Y, Weng W, Porod W, Liu RW, Huang YF. Quantum cellular neural networks Superlattices and Microstructures. 20: 476-478. DOI: 10.1006/Spmi.1996.0104  0.586
1995 Nevin ST, Tóth G, Weltrowska G, Schiller PW, Borsodi A. Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist. Life Sciences. 56: PL225-30. PMID 7885186 DOI: 10.1016/0024-3205(95)00012-U  0.381
1995 Borsodi A, Tóth G. Characterization of opioid receptor types and subtypes with new ligands Annals of the New York Academy of Sciences. 757: 339-352. PMID 7611691 DOI: 10.1111/J.1749-6632.1995.Tb17492.X  0.316
1995 Ötvös F, Hosztafi S, Simon C, Tóth G. Synthesis of high specific activity [15,16-3H2]buprenorphine Journal of Labelled Compounds and Radiopharmaceuticals. 36: 79-83. DOI: 10.1002/Jlcr.2580360110  0.343
1994 Nevin ST, Kabasakal L, Otvös F, Töth G, Borsodi A. Binding characteristics of the novel highly selective delta agonist, [3H]IIe5,6deltorphin II. Neuropeptides. 26: 261-5. PMID 8028715 DOI: 10.1016/0143-4179(94)90080-9  0.371
1994 Kitchen I, Leslie FM, Borsodi A, Toth G, Melchiorri P, Negri L. Weaning-induced changes in δ-opioid receptor subtypes: Evidence from autoradiography and in situ hybridisation Regulatory Peptides. 54: 153-154. DOI: 10.1016/0167-0115(94)90436-7  0.314
1994 Belcheva M, McHale R, Toth G, Borsodi A, Coscia C. Nuclear matrix associated opioid binding sites are increased upon D-Ala2-D-Leu5-enkephalin-induced down-regulation in NG108-15 cells Regulatory Peptides. 54: 21-22. DOI: 10.1016/0167-0115(94)90369-7  0.334
1993 Wild KD, Horan PJ, Misicka A, Lipkowski A, Haaseth RC, Matsunaga TO, Hruby VJ, Toth G, Borsodi A, Yamamura HI. Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors. European Journal of Pharmacology. 246: 25-31. PMID 8394818 DOI: 10.1016/0922-4106(93)90005-T  0.349
1993 Nevin ST, Toth G, Nguyen TM, Schiller PW, Borsodi A. Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP. Life Sciences. 53: PL57-62. PMID 8393120 DOI: 10.1016/0024-3205(93)90649-N  0.383
1993 Wild KD, Fang L, McNutt RW, Chang KJ, Toth G, Borsodi A, Yamamura HI, Porreca F. Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodium. European Journal of Pharmacology. 246: 289-92. PMID 8223952 DOI: 10.1016/0922-4106(93)90044-A  0.352
1993 Tóth G, Ötvös F, Hosztafi S. Tritium Labelling of Naltrindole, a δ‐Receptor‐Selective Opioid Antagonist via 1‐Bromonaltrexone Helvetica Chimica Acta. 76: 2274-2278. DOI: 10.1002/Hlca.19930760612  0.317
1992 Sharma SD, Toth G, Hruby VJ. A simple general method for (radio)iodination of a phenylalanine residue in peptides: preparation of [cyclic][D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin, a peptide with extraordinary selectivity for .delta.-opioid receptors. [Erratum to document cited in CA115(7):72200f] The Journal of Organic Chemistry. 57: 3750-3750. DOI: 10.1021/Jo00039A052  0.31
1992 Ötvös F, Tóth G, Schmidhammer H. Tritium labelling of cyprodime (= (-)-17-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one), a μ receptor-selective opioid antagonist Helvetica Chimica Acta. 75: 1718-1720. DOI: 10.1002/Hlca.19920750524  0.342
1991 Oktem HA, Moitra J, Benyhe S, Toth G, Lajtha A, Borsodi A. Opioid receptor labeling with the chloromethyl ketone derivative of [3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-Ol (DAMGO) II: Covalent labeling of Mu opioid binding site by 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl ketone Life Sciences. 48: 1763-1768. PMID 1850495 DOI: 10.1016/0024-3205(91)90214-V  0.37
1991 Hruby VJ, Toth G, Gehrig CA, Kao LF, Knapp R, Lui GK, Yamamura HI, Kramer TH, Davis P, Burks TF. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin. Journal of Medicinal Chemistry. 34: 1823-30. PMID 1648137 DOI: 10.1021/Jm00110A010  0.327
1989 Vaughn LK, Knapp RJ, Toth G, Wan YP, Hruby VJ, Yamamura HI. A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalin. Life Sciences. 45: 1001-8. PMID 2552241 DOI: 10.1016/0024-3205(89)90154-9  0.359
1989 Benyhe S, Hoffmann G, Varga E, Hosztafi S, Toth G, Borsodi A, Wollemann M. Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitro. Life Sciences. 44: 1847-1857. PMID 2472540 DOI: 10.1016/0024-3205(89)90302-0  0.344
1988 Varga E, Tóth G, Hepp J, Benyhe S, Simon J, Medzihradszky K, Borsodi A. Synthesis of 3H-Tyr-D-Ala-Gly-N(Me)Phe chloromethyl ketone--an opioid affinity label. Neuropeptides. 12: 135-139. PMID 2853836 DOI: 10.1016/0143-4179(88)90044-3  0.359
1987 Szücs M, Borsodi A, Bogdány A, Gaál J, Batke J, Toth G. Detailed analysis of heterogeneity of [3H]naloxone binding sites in rat brain synaptosomes Neurochemical Research. 12: 581-587. PMID 3039389 DOI: 10.1007/Bf00971005  0.325
1987 Simon J, Szücs M, Benyhe S, Tóth G, Hepp J, Borsodi A, Wollemann M, Medzihradszky K. Covalent labeling of opioid receptors with 3HDAla2Leu5-enkephalin chloromethyl ketone II. Binding characteristics in frog brain membranes Life Sciences. 41: 185-192. PMID 3037220 DOI: 10.1016/0024-3205(87)90491-7  0.366
1987 Varga E, Toth G, Benyhe S, Hosztafi S, Borsodi A. Synthesis and binding of 3H-oxymorphazone to rat brain membranes. Life Sciences. 40: 1579-1588. PMID 2436019 DOI: 10.1016/0024-3205(87)90123-8  0.349
1986 Newman EL, Borsodi A, Toth G, Hepp F, Barnard EA. Mu-receptor specificity of the opioid peptide irreversible reagent, [3H]DALECK. Neuropeptides. 8: 305-15. PMID 3029618 DOI: 10.1016/0143-4179(86)90002-8  0.374
1986 Borsodi A, Toth G. Microtubule dissassembly increases the number of opioid receptor binding sites in rat cerebrum membranes Neuropeptides. 8: 51-54. PMID 3020468 DOI: 10.1016/0143-4179(86)90064-8  0.357
1986 Simon J, Benyhe S, Abutidze K, Borsodi A, Szüs M, Tóth G, Wollemann M. Kinetics and Physical Parameters of Rat Brain Opioid Receptors Solubilized by Digitonin and CHAPS Journal of Neurochemistry. 46: 695-701. PMID 3005492 DOI: 10.1111/J.1471-4159.1986.Tb13027.X  0.328
1985 Benyhe S, Tóth G, Kevei J, Szücs M, Borsodi A, Gléria KD, Szécsi J, Süli-Vargha H, Medzihradszky K. Characterization of rat brain opioid receptors by [Tyr-3,5-3H]1, D-Ala2, Leu5-enkephalin binding. Neurochemical Research. 10: 627-635. PMID 2989719 DOI: 10.1007/Bf00964402  0.39
1984 Szücs M, Tóth G, Benyhe S, Szécsi J, Wollemann M, Medzihradszky K. Binding of Reversible and Irreversible Ligands to Rat Brain Opiate Receptors Acta Biochimica Et Biophysica Academiae Scientiarum Hungaricae. 17: 493-496. DOI: 10.1007/978-1-4684-4631-9_57  0.343
1981 Borsodi A, Bogdany A, Kramer M, Toth G, Wolleman M. Agonist versus antagonist binding to opiate receptors in rat brain stem Biochemical Society Transactions. 9. DOI: 10.1042/Bst009163Pb  0.308
Show low-probability matches.